XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Oct. 31, 2025
Jan. 31, 2025
Current assets:    
Cash and cash equivalents $ 1,215,877 $ 1,349,380
Marketable securities 6,727,428 6,442,329
Accounts receivable, net of allowances of $18,128 and $22,078 as of October 31, 2025 and January 31, 2025, respectively 417,693 495,228
Deferred contract acquisition costs, current 175,047 188,358
Prepaid expenses and other current assets 178,922 200,679
Total current assets 8,714,967 8,675,974
Deferred contract acquisition costs, noncurrent 118,316 123,464
Property and equipment, net 284,851 330,475
Operating lease right-of-use assets 40,870 55,900
Strategic investments 1,052,604 591,481
Goodwill 307,295 307,295
Deferred tax assets 746,400 749,759
Other assets, noncurrent 125,508 154,073
Total assets 11,390,811 10,988,421
Current liabilities:    
Accounts payable 12,843 8,345
Accrued expenses and other current liabilities 514,778 558,562
Deferred revenue, current 1,431,802 1,336,387
Total current liabilities 1,959,423 1,903,294
Deferred revenue, noncurrent 12,682 17,274
Operating lease liabilities, noncurrent 28,072 37,406
Other liabilities, noncurrent 103,794 95,363
Total liabilities 2,103,971 2,053,337
Commitments and contingencies (Note 6)
Stockholders’ equity:    
Common stock, $0.001 par value per share, 2,000,000,000 Class A shares authorized as of October 31, 2025 and January 31, 2025; 266,345,564 and 263,113,866 shares issued and outstanding as of October 31, 2025 and January 31, 2025, respectively; 300,000,000 Class B shares authorized as of October 31, 2025 and January 31, 2025; 30,678,509 and 42,626,998 shares issued and outstanding as of October 31, 2025 and January 31, 2025, respectively 296 305
Additional paid-in capital 4,250,595 5,130,271
Accumulated other comprehensive income 10,363 4,990
Retained earnings 5,025,586 3,799,518
Total stockholders’ equity 9,286,840 8,935,084
Total liabilities and stockholders’ equity $ 11,390,811 $ 10,988,421